Literature DB >> 23545207

Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat.

Jin Ju1, Dong Jin Shin, Yoon Chan Na, Myung Ha Yoon.   

Abstract

The purpose of this study was to examine the effects of intrathecal nociceptin for neuropathic pain and determine the role of spinal opioid receptor types. Neuropathic pain was induced by ligation of L5 and L6 spinal nerves in male Sprague-Dawley rats. Several antagonists were intrathecally administered to evaluate the action mechanisms of nociceptin: nonselective opioid receptor antagonist (naloxone), μ opioid receptor antagonist (CTOP), δ opioid receptor antagonist (naltrindole) and κ opioid receptor antagonist (GNTI). The levels of opioid receptor proteins were examined by Western blotting. Intrathecal nociceptin produced dose-dependent antiallodynia. Intrathecal naloxone reversed the antinociception of nociceptin. Intrathecal CTOP, naltrindole and GNTI reversed the antinociceptive effect of nociceptin. Western blots showed that the levels of spinal opioid receptor proteins did not differ between rats with neuropathic pain and naïve rats. Intrathecal nociceptin increased the level of δ opioid receptor protein compared with that of nerve ligated rats, while the levels of μ, and κ opioid receptor proteins were unchanged. These results suggest that intrathecal nociceptin produced antiallodynic effect in spinal nerve ligation-induced neuropathic pain. All three types of spinal μ, δ, and κ opioid receptors were involved in the antiallodynic mechanism of nociceptin.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23545207     DOI: 10.1016/j.neulet.2013.03.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

2.  Nerve Decompression Improves Spinal Synaptic Plasticity of Opioid Receptors for Pain Relief.

Authors:  To-Jung Tseng; Ming-Ling Yang; Yu-Lin Hsieh; Miau-Hwa Ko; Sung-Tsang Hsieh
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

3.  Involvement of Opioid Peptides in the Analgesic Effect of Spinal Cord Stimulation in a Rat Model of Neuropathic Pain.

Authors:  Fu-Jun Zhai; Song-Ping Han; Tian-Jia Song; Ran Huo; Xing-Yu Lan; Rong Zhang; Ji-Sheng Han
Journal:  Neurosci Bull       Date:  2022-04-09       Impact factor: 5.271

4.  Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.

Authors:  Akihiko Ozawa; Gloria Brunori; Andrea Cippitelli; Nicholas Toll; Jennifer Schoch; Brigitte L Kieffer; Lawrence Toll
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

5.  The nociceptin/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: Model validation and pharmacological evaluation.

Authors:  Sonny H J Sliepen; Johanna Korioth; Thomas Christoph; Thomas M Tzschentke; Marta Diaz-delCastillo; Anne-Marie Heegaard; Kris Rutten
Journal:  Br J Pharmacol       Date:  2020-01-21       Impact factor: 8.739

6.  Injury-Dependent and Disability-Specific Lumbar Spinal Gene Regulation following Sciatic Nerve Injury in the Rat.

Authors:  Paul J Austin; Alison L Bembrick; Gareth S Denyer; Kevin A Keay
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

7.  Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.

Authors:  Thomas Christoph; Robert Raffa; Jean De Vry; Wolfgang Schröder
Journal:  Pharmacol Res Perspect       Date:  2018-11-28

8.  Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.

Authors:  Qian Huang; Xiao-Fang Mao; Hai-Yun Wu; Teng-Fei Li; Ming-Li Sun; Hao Liu; Yong-Xiang Wang
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

9.  Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.

Authors:  Kinga Sałat; Anna Furgała; Robert Sałat
Journal:  Inflammopharmacology       Date:  2017-10-25       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.